(Q77291792)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734694%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

review article

1 reference

title

Erythropoietin, with and without granulocyte-colony stimulating factor (G-CSF), in the treatment of myelodysplastic syndrome (MDS) patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734694%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

main subject

myelodysplastic syndrome

1 reference

K Miller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734694%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 May 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734694%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734694%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

22 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734694%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

S13-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734694%20AND%20SRC:MED&resulttype=core&format=json

The myelodysplastic syndromes: current approaches to therapy

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900035-6

7 January 2021

Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900035-6

7 January 2021

The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900035-6

7 January 2021

Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900035-6

7 January 2021

Treatment of the anemia of progressive renal failure with recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900035-6

7 January 2021

The use of r-HuEpo in the treatment of anaemia related to myelodysplasia (MDS).

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900035-6

7 January 2021

Efficacy of erythropoietin in the myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900035-6

7 January 2021

Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900035-6

7 January 2021

Lymphocyte subsets in hemodialysis patients treated with recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900035-6

7 January 2021

Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900035-6

7 January 2021

Failure of combination therapy with recombinant granulocyte colony-stimulating factor and erythropoietin in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900035-6

7 January 2021

10.1016/S0145-2126(98)00035-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734694%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference